Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China-Reference-Cited by-同舟云学术

Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China

Published:2020-07-22 Issue:12 Volume:76 Page:1755-1763
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Chen Peng-yuan,Liu Yuan-hui,Duan Chong-yang,Fan Hua-lin,Zeng Li-huan,Guo Wei,Jiang Lei,Wei Xue-biao,He Wen-fei,Tao Sha,Guo Zhi-qiang,Chen Ji-yan,Tan Ning,He Peng-cheng^ORCID

Funder

the Outstanding Young Talent Program of Guangdong Provincial People’s Hospital

Science and Technology Planning Project of Guangzhou City

China Youth Research Funding

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-020-02966-1.pdf

Reference29 articles.

1. Afilalo J, Majdan AA, Eisenberg MJ (2007) Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials. HEART. 93:914–921

2. Gibson CM, Pride YB, Hochberg CP, Sloan S, Sabatine MS, Cannon CP, TIMI Study Group (2009) Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: a PROVE IT-TIMI 22 (pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22) substudy. J Am Coll Cardiol 54:2290–2295

3. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators (2001) Effects of atorvastatin on early represent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285:1711–1718

4. Xing Y, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Yang N, Zhou M, Zhao D, CCC-ACS Investigators (2019) Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: findings from the improving Care for Cardiovascular Disease in China (CCC) project. Am Heart J 212:120–128

5. Rodriguez F, Maron DJ, Knowles JW, et al. (2019) Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease. JAMA CARDIOL